Human herpesvirus 6 envelope cholesterol is required for virus entry

References

1. Akkapaiboon P., Mori Y., Sadaoka T., Yonemoto S., Yamanishi K. 2004; Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope. J Virol 78:7969–7983 [CrossRef]
   [Google Scholar]
2. Bender F. C., Whitbeck J. C., Ponce de Leon M., Lou H., Eisenberg R. J., Cohen G. H. 2003; Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. J Virol 77:9542–9552 [CrossRef]
   [Google Scholar]
3. Campbell S. M., Crowe S. M., Mak J. 2001; Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J Clin Virol 22:217–227 [CrossRef]
   [Google Scholar]
4. Campbell S. M., Crowe S. M., Mak J. 2002; Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS 16:2253–2261 [CrossRef]
   [Google Scholar]
5. Dhepakson P., Mori Y., Jiang Y. B., Huang H. L., Akkapaiboon P., Okuno T., Yamanishi K. 2002; Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. J Gen Virol 83:847–854
   [Google Scholar]
6. Graham D. R. M., Chertova E., Hilburn J. M., Arthur L. O., Hildreth J. E. K. 2003; Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with β -cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. J Virol 77:8237–8248 [CrossRef]
   [Google Scholar]
7. Guyader M., Kiyokawa E., Abrami L., Turelli P., Trono D. 2002; Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J Virol 76:10356–10364 [CrossRef]
   [Google Scholar]
8. Mori Y., Seya T., Huang H. L., Akkapaiboon P., Dhepakson P., Yamanishi K. 2002; Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J Virol 76:6750–6761 [CrossRef]
   [Google Scholar]
9. Mori Y., Akkapaiboon P., Yang X., Yamanishi K. 2003a; The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope. J Virol 77:2452–2458 [CrossRef]
   [Google Scholar]
10. Mori Y., Yang X., Akkapaiboon P., Okuno T., Yamanishi K. 2003b; Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol 77:4992–4999 [CrossRef]
    [Google Scholar]
11. Mori Y., Akkapaiboon P., Yonemoto S. & 7 other authors 2004; Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J Virol 78:4609–4616 [CrossRef]
    [Google Scholar]
12. Phalen T., Kielian M. 1991; Cholesterol is required for infection by Semliki Forest virus. J Cell Biol 112:615–623 [CrossRef]
    [Google Scholar]
13. Salahuddin S. Z., Ablashi D. V., Markham P. D. & 8 other authors 1986; Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596–601 [CrossRef]
    [Google Scholar]
14. Santoro F., Kennedy P. E., Locatelli G., Malnati M. S., Berger E. A., Lusso P. 1999; CD46 is a cellular receptor for human herpesvirus 6. Cell 99:817–827 [CrossRef]
    [Google Scholar]
15. Santoro F., Greenstone H. L., Insinga A., Liszewski M. K., Atkinson J. P., Lusso P., Berger E. A. 2003; Interaction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46. J Biol Chem 278:25964–25969 [CrossRef]
    [Google Scholar]
16. Sun X., Whittaker G. R. 2003; Role for influenza virus envelope cholesterol in virus entry and infection. J Virol 77:12543–12551 [CrossRef]
    [Google Scholar]
17. Viard M., Parolini I., Sargiacomo M., Fecchi K., Ramoni C., Ablan S., Ruscetti F. W., Wang J. M., Blumenthal R. 2002; Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells. J Virol 76:11584–11595 [CrossRef]
    [Google Scholar]
18. Waarts B.-L., Bittman R., Wilschut J. 2002; Sphingolipid and cholesterol dependence of alphavirus membrane fusion: lack of correlation with lipid raft formation in target liposomes. J Biol Chem 277:38141–38147 [CrossRef]
    [Google Scholar]
19. Yamanishi K., Okuno T., Shiraki K., Takahashi M., Kondo T., Asano Y., Kurata T. 1988; Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet i:1065–1067
    [Google Scholar]
20. Zerr D. M., Corey L., Kim H. W., Huang M.-L., Nguy L., Boeckh M. 2005a; Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 40:932–940 [CrossRef]
    [Google Scholar]
21. Zerr D. M., Meier A. S., Selke S. S. & 8 other authors 2005b; A population-based study of primary human herpesvirus 6 infection. N Engl J Med 352:768–776 [CrossRef]
    [Google Scholar]